158 related articles for article (PubMed ID: 24785004)
1. Aβ dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies.
O'Malley TT; Oktaviani NA; Zhang D; Lomakin A; O'Nuallain B; Linse S; Benedek GB; Rowan MJ; Mulder FA; Walsh DM
Biochem J; 2014 Aug; 461(3):413-26. PubMed ID: 24785004
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils.
O'Nuallain B; Freir DB; Nicoll AJ; Risse E; Ferguson N; Herron CE; Collinge J; Walsh DM
J Neurosci; 2010 Oct; 30(43):14411-9. PubMed ID: 20980598
[TBL] [Abstract][Full Text] [Related]
3. Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process.
Wahlström A; Cukalevski R; Danielsson J; Jarvet J; Onagi H; Rebek J; Linse S; Gräslund A
Biochemistry; 2012 May; 51(21):4280-9. PubMed ID: 22554145
[TBL] [Abstract][Full Text] [Related]
4. Aβ40(L17A/F19A) mutant diminishes the aggregation and neurotoxicity of Aβ40.
Chen YR; Huang HB; Lo CJ; Wang CC; Su CL; Liu HT; Shiao MS; Lin TH; Chen YC
Biochem Biophys Res Commun; 2011 Feb; 405(1):91-5. PubMed ID: 21216230
[TBL] [Abstract][Full Text] [Related]
5. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure.
Goldblatt G; Cilenti L; Matos JO; Lee B; Ciaffone N; Wang QX; Tetard L; Teter K; Tatulian SA
FEBS J; 2017 May; 284(9):1355-1369. PubMed ID: 28294556
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain-derived synaptic plasticity-disrupting Aβ.
O'Nuallain B; Klyubin I; Mc Donald JM; Foster JS; Welzel A; Barry A; Dykoski RK; Cleary JP; Gebbink MF; Rowan MJ; Walsh DM
J Neurochem; 2011 Oct; 119(1):189-201. PubMed ID: 21781116
[TBL] [Abstract][Full Text] [Related]
7. Role of amyloid-beta glycine 33 in oligomerization, toxicity, and neuronal plasticity.
Harmeier A; Wozny C; Rost BR; Munter LM; Hua H; Georgiev O; Beyermann M; Hildebrand PW; Weise C; Schaffner W; Schmitz D; Multhaup G
J Neurosci; 2009 Jun; 29(23):7582-90. PubMed ID: 19515926
[TBL] [Abstract][Full Text] [Related]
8. The Aggregation Paths and Products of Aβ42 Dimers Are Distinct from Those of the Aβ42 Monomer.
O'Malley TT; Witbold WM; Linse S; Walsh DM
Biochemistry; 2016 Nov; 55(44):6150-6161. PubMed ID: 27750419
[TBL] [Abstract][Full Text] [Related]
9. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N.
Tatini F; Pugliese AM; Traini C; Niccoli S; Maraula G; Ed Dami T; Mannini B; Scartabelli T; Pedata F; Casamenti F; Chiti F
Neurobiol Aging; 2013 Sep; 34(9):2100-9. PubMed ID: 23601807
[TBL] [Abstract][Full Text] [Related]
11. DHPC strongly affects the structure and oligomerization propensity of Alzheimer's Aβ(1-40) peptide.
Dahse K; Garvey M; Kovermann M; Vogel A; Balbach J; Fändrich M; Fahr A
J Mol Biol; 2010 Nov; 403(4):643-59. PubMed ID: 20851128
[TBL] [Abstract][Full Text] [Related]
12. Direct Evidence of the Presence of Cross-Linked Aβ Dimers in the Brains of Alzheimer's Disease Patients.
Vázquez de la Torre A; Gay M; Vilaprinyó-Pascual S; Mazzucato R; Serra-Batiste M; Vilaseca M; Carulla N
Anal Chem; 2018 Apr; 90(7):4552-4560. PubMed ID: 29537826
[TBL] [Abstract][Full Text] [Related]
13. Low-n oligomers as therapeutic targets of Alzheimer's disease.
Ono K; Yamada M
J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
[TBL] [Abstract][Full Text] [Related]
14. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
[TBL] [Abstract][Full Text] [Related]
15. Monte Carlo study of the formation and conformational properties of dimers of Aβ42 variants.
Mitternacht S; Staneva I; Härd T; Irbäck A
J Mol Biol; 2011 Jul; 410(2):357-67. PubMed ID: 21616081
[TBL] [Abstract][Full Text] [Related]
16. Conformations and biological activities of amyloid beta peptide 25-35.
Millucci L; Ghezzi L; Bernardini G; Santucci A
Curr Protein Pept Sci; 2010 Feb; 11(1):54-67. PubMed ID: 20201807
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
Shankar GM; Li S; Mehta TH; Garcia-Munoz A; Shepardson NE; Smith I; Brett FM; Farrell MA; Rowan MJ; Lemere CA; Regan CM; Walsh DM; Sabatini BL; Selkoe DJ
Nat Med; 2008 Aug; 14(8):837-42. PubMed ID: 18568035
[TBL] [Abstract][Full Text] [Related]
18. In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.
Walsh DM; Hartley DM; Condron MM; Selkoe DJ; Teplow DB
Biochem J; 2001 May; 355(Pt 3):869-77. PubMed ID: 11311152
[TBL] [Abstract][Full Text] [Related]
19. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
20. Globular and protofibrillar aβ aggregates impair neurotransmission by different mechanisms.
Moreth J; Kroker KS; Schwanzar D; Schnack C; von Arnim CA; Hengerer B; Rosenbrock H; Kussmaul L
Biochemistry; 2013 Feb; 52(8):1466-76. PubMed ID: 23374097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
